Another in vitro test demonstrated that HNRNPA2B1 promoted the proliferation of prostate cancer cells in an m6A-dependent manner, which might involve alternative splicing of genes participating in RNA processing, cell cycle, DNA replication and repair, chromatin organization, translation, and mitochondrion-related processes. Here, HNRNPA2B1 is linked to prostate carcinoma.